The cystatins are a large class of proteins that function as inhibitors of cysteine proteases, including the cathepsins. Structural and functional comparisons suggest that the cystatins comprise a single evolutionary superfamily, presumably derived from a common ancestor (Rawlings and Barrett 1990 ). This superfamily is classified into three distinct families of closely related proteins--the intracellular stefins (family-i), the secretory cystatins (family-2), and the kininogens (family-3) (Barrett et al. 1986a ). Family-1 cystatins are -lO0-amino-acid single-chain proteins that lack disulfide bonds.
Of the family-1 type cystatins, stefin A and cystatin B (also known as stefin B) have been studied the most extensively. Both are 98-aminoacid proteins that have been identified in several different mammalian species. Stefin A is found in high concentrations in various types of epithelial cells and polymorphonuclear leukocytes in the liver (Barrett et al. 1986b) . In contrast, cystatin B is widely distributed among different cell types and tissues (Barrett et al. 1986b; Pennacchio et al. 1996) . Although stefins lack an export signal sequence and are generally thought to function intracellularly, they have also been found in extracellular fluid (Abrahamson et al. 1986 ). The amino acid sequences of human, rat, and bovine cystatin B are known (Ritonja et al. 1985; Sato et al. 1990; Turk et al. 1992) , and the X-ray structure of the h u m a n protein complexed with carboxymethyl-papain has been determined (Stubbs et al. 1990b) .
Recently, we showed that defects in the human cystatin B gene are responsible for progressive m y o c l o n u s epilepsy of the UnverrichtLundborg type (EPM1). EPM1 is inherited as an autosomal recessive disease characterized by severe stimulus-sensitive myoclonus, tonic-clonic seizures, and progressive neurological deterioration (Berkovic et al. 1985) . The cystatin B gene is expressed ubiquitously and its gene product is thought to have a general role in the inactivation of proteases that escape from the lysosome (Turk and Bode 1991 specific to the central nervous system. To understand the relationship between this protein and the symptoms of this disease, we are studying the expression and biochemical properties of the mouse protein, as well as working toward developing an animal model for EPM1 by disrupting the cystatin B gene in the mouse. As a first step toward these goals, we have isolated and characterized the mouse cystatin B gene. Here we report its structure, mRNA expression patterns, and chromosomal location in the mouse genome.
RESULTS

Identification of the Mouse Cystatin B Gene
To identify the mouse cystatin B gene, we designed oligonucleotides based on the known h u m a n cystatin B and rat cystatin 13 cDNA and genomic sequences (Sato et al. 1990 (Sato et al. , 1992 Pennacchio et al. 1996; K.S. Bhat, unpubl.) . One pair of primers (FIOO/RIO0; see Methods) yielded a single, -350-bp long PCR product that is 70% identical to the rat cyst a t i n 13 g e n o m i c n u c l e o t i d e sequence. We used this primer pair to screen a mouse bacterial artificial chromosome (BAC) genomic library by using the polymerase chain reaction (PCR) and identified BAC clone 310P21 (see Methods). Restriction and hybridization analysis of this BAC clone indicated that the complete mouse cystatin B gene is present in two overlapping DNA fragments: a 6-kb SacI fragment and a 1.6-kb PstI fragment. We subcloned both of these fragments and determined the nucleotide sequence of the gene and its flanking regions ( Fig. 1 ).
Nucleotide Sequence Analysis
The genomic sequence of the mouse cystatin B gene is shown in Figure 1 . We compared the nucleic acid sequence with that of the h u m a n and rat cystatin B (13) genes and found that all three genes contain 3 exons and 2 introns (Sato et al. 1992; Pennacchio et al. 1996) . The mouse open reading frame is contained in all three exons and is 294 bp in length, identical to that found in the h u m a n and rat genes. The nucleotide sequence identity between the mouse cystatin B coding sequence and that of the rat and h u m a n is 90% and 77%, respectively. The mouse sequence flanking the putative start codon (5'-ACTGCTGCCAA-GATG-3') m a t c h e s the Kozak c o n s e n s u s sequence at most relevant positions (Kozak 1987 ). The mouse cystatin B gene has an e x o n -i n t r o n structure identical to that of the h u m a n and rat genes, and contains GT to AG consensus sequences at its intron/exon junctions (Breathnach and C h a m b o n 1981). The sizes of introns 1 and 2 in the mouse cystatin B gene are 1070 and 282 bp, respectively. In comparison, the sizes of the rat and h u m a n cystatin B introns 1 and 2 are 977 and 480 bp, and 1445 and 325 bp, respectively. The putative promoter region of the mouse gene is GC rich and contains no obvious TATAA or CCAAT consensus sequences, similar to promoters of other genes that are expressed ubiquitously (Dynan 1986 ). This gene has three GC boxes (GGGCGG) identical to those found in other genes where Spl transcription factors are known to bind (Pugh and Tjian 1990) (Fig. 1) .
Analysis of the Deduced Mouse Cystatin B Amino Acid Sequence
The mouse cystatin B gene encodes a predicted 9 8 -a m i n o -a c i d protein, which is identical in length to that of the rat, human, and bovine cystatin B proteins. A l i g n m e n t of the d e d u c e d mouse cystatin B protein sequence reveals 86%, 79%, and 71% amino acid identity and 95%, 88%, and 82% amino acid conservation with the rat, human, and bovine cystatin B protein sequences, respectively (Fig. 2) .
Ten of the 11 m a m m a l i a n stefins whose amino acid sequences were determined before our study contain the seq u e n c e QVVAG located approximately in the middle of the primary sequence of the p r o t e i n s . This p e n t a p e p t i d e comprises the first [3-hairpin loop of stefins, and has been shown to interact with the targ e t e n z y m e in i n h i b i t o r / protease complexes (Stubbs et al. 1990b ). The first exception to this conservation was bovine cystatin B, which contains the sequence QL-VAG at the equivalent position (Turk et al. 1992 ). The valine-to-leucine alteration in the bovine protein has little effect on its activity (Turk et al. 1992) . Our analysis of the deduced mouse cystatin B amino acid sequence indicates that it contains the segment QIVAG within this region of the protein. Although this change is conservative (valine to isoleucine), mutagenesis studies with the h u m a n protein indicate that isoleucine in this position of the pentapeptide results in a fourfold reduction in inhibitory activity against papain (Jerala et al. 1990) . Whether this amino acid difference in the mouse protein results in lowered activity remains to be determined.
Mouse Cystatin B mRNA Expression
To determine the tissue distribution of cystatin B mRNA in the mouse, we hybridized a cDNA probe to a Northern blot containing RNA from multiple tissues (Fig. 3) . As an internal standard, we also hybridized a [3-actin probe to the same Northern blot. Similar to results seen in humans, all mouse tissues we tested have high levels of cystatin B mRNA at the expected size o f -6 0 0 nucleotides. On the basis of normalizing each lane to [3-actin signals, heart, liver, and kidney have fivefold higher levels of mRNA t h a n spleen and testis, and twice the levels of mRNA of brain, lung, and skeletal muscle.
Chromosomal Localization of the Mouse Cystatin B Gene
We determined the chromosomal location of the
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Cold Spring Harbor Laboratory Press on May 14, 2012 -Published by genome.cshlp.org Downloaded from (Rowe et al. 1994 ; L. Rowe, pers. comm.). We used oligonucleotides (F100/R100) flanking intron 2 to amplify DNA from the two parental mouse backcross strains Mus musculus and M. spretus, and detected a PstI restriction fragment length polymorphism in the amplified fragments. We found that M. musculus contains a single PstI restriction site in this fragment, whereas M. spretus lacks this site. By using this assay to distinguish the two strains, we mapped the mouse cystatin B gene to chromosome 10 (Fig. 4) . This pedigree analysis indicated that the mouse cystatin B gene is linked to the loci DlOMit20, D10Mit65, DlOMit67, DlOMit11, and DlOMitlO (Fig. 4A) . Furthermore, no recombination events were identified between the gene and the loci Adn, Col6al, D10Mit22, Gng7, Matk, Pcsk4 , and Tcfe2a (Fig. 4B) . These results establish the order and genetic distances between these loci as DlOMit20-(6.38 cM + 2.52 S.E.)- [Stfb, Adn, Co16al, D10Mit22, Gng7, Matk, Pcsk4, Tcfe2a] 4A ).
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DISCUSSION
Despite a substantial amount of knowledge about the biochemical properties of the cystatin B protein from several mammalian species, the reasons that defects in the gene lead to EPM1 in humans are not understood. One motivation for isolating and characterizing the mouse cystatin B gene is to provide a means to study the protein and its expression in an experimentally manipulatable mammalian system. In addition, the mouse gene provides a reagent for generating and studying an animal model for the disease. The clones and molecular characterization reported here can be used to construct mouse embryonic stem cells with a completely disrupted cystatin B gene. Because the mutations that we identified in the cystatin B gene in patients with EPM1 may all result in some level of functional protein, it is not yet known whether complete or partial loss of cystatin B activity is the cause of the disease (Pennacchio et al. 1996) . It may be necessary to generate mice with these subtle mutations (a splice site mutation and a stop codon mutation at position 67) to produce EPMl-like symptoms, as it is possible that complete loss of function of the gene would be lethal. A successful mouse model of EPM1 will provide a reagent for understanding the progression of symptoms and neuropathology, for developing therapies and for testing hypotheses regarding the roles of particular target proteases in the various symptoms of the disease.
The human cystatin B gene is located on human chromosome 21q22.3, between two syntenic regions of the chromosome that are conserved with portions of two different mouse chromosomes. The synteny in the genomic region proximal to the human cystatin B gene, between ~-A-crystallin (CRYA) and cystathionine-13-synthase (CBS), is conserved in the proximal portion of mouse chromosome 17 (Munke et al. 1988; Stubbs et al. 1990a ). The synteny in the genomic region distal to the human cystatin B gene, between the liver-type phosphofructokinase (PFKL), the type VI collagen A1 gene (COL6A1), and the [3 subunit of the Mac-1 leukocyte surface glycoprotein family (S100B), is conserved in a region of mouse chromosome 10 (Justice et MacDonald et al. 1991; Irving et al. 1994 ). The mapping of the mouse cystatin B gene to mouse chromosome 10 reported here extends the known boundaries of conservation between this region of h u m a n c h r o m o s o m e 21q22.3 and the mouse genome. Stfb, Adn, Col6al, D10Mit22, Gng7, Matk, Pcsk4, and Tcfe2a, and gene can be used to d e t e r m i n e w h e t h e r t h e gene is i n v o l v e d in a b e r r a n t p h e n o t y p e s in existing m u t a n t mice. The genes for t h e three m o u s e mutants grizzled, mocha, a n d jittery are located o n m o u s e c h r o m o s o m e 10, near t h e region t h a t contains t h e cystatin B gene (Taylor et al. 1993) . At t h e c u r r e n t level of r e s o l u t i o n of m a p p i n g of these genes, it is reasonable to consider the cyst a t i n B gene as a c a n d i d a t e for a n y of these diseases. In this regard, jittery is of particular interest because it displays early o n s e t seizures as part of its p h e n o t y p e (DeOme 1945), m a k i n g it a possible m o u s e m o d e l of EPM1. Further m a p p i n g of the m o u s e jittery locus relative to the cystatin B gene a n d m u t a t i o n analysis, if w a r r a n t e d o n the basis of m a p p i n g results, will be necessary to test this hypothesis.
METHODS
Isolation of Genomic Clones
We isolated BAC 310P21 by PCR screening a pooled mouse genomic BAC library (Research Genetics, Inc., Huntsville, AL; DNA pools were a gift from Greg Lennon, Lawrence Livermore National Laboratory, Livermore, CA) with the oligonucleotides FIO0 (5'-GGGACAAACTACTTCAT-CAAGGT-3') and R100 (5'-GGCTTGTTTTCATGAGGGAG-3'), which were designed on the basis of the human cystatin B nucleotide sequence. The PCR conditions were as follows: An initial incubation at 94~ for 5 min followed by 30 cycles for 30 sec at 94~ 30 sec at 60~ 1 min at 72~ with a final incubation for 10 min at 72~ We subcloned a 6.0-kb SacI fragment and a 1.6-kb PstI fragment from this BAC clone into plasmid vector pBSIISK+ to yield pBS-SacI-6 and pBS-PstI-1.6, respectively.
DNA Sequencing
We isolated DNA from overnight cultures by standard al-
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Cold Spring Harbor Laboratory Press on May 14, 2012 -Published by genome.cshlp.org Downloaded from kaline lysis and a Qiagen column. The 6-kb pBS-SacI-6 was digested independently with the blunt end generating restriction enzymes AluI, EcoRV, HaeIII, HincII, HpaI, NlaI, PvuII, RsaI, and StuI. Digests were pooled subsequently and subcloned into the EcoRV site of plasmid vector (pBSIISK+) for automated DNA sequencing. We performed sequencing reactions with fluorescently labeled M13-21F and M13R primers and analyzed the reactions with an Applied Biosystems 377A sequencer. We assembled sequence data with the sequence analysis program Sequencher 3.0 (Gene Codes Corporation). PCR products were purified with a Centricon-lO0 concentrator (Amicon, Beverly, MA) and cloned into a plasmid vector.
Hybridization Analysis
BAC DNA was digested with restriction enzymes (New England Biolabs) according to the manufacturer's recommendations. Digested DNA was separated by gel electrophore sis and transferred to Hybond-N § membranes (Amersham). Membranes were baked for 2 hr at 85~ followed by hybridization with either [~-32p]dATP randomly primed probes or [~-32p]dATP T 4 kinase end-labeled oligonucleotides.
A mouse cystatin B cDNA probe was generated by the random labeling of an RT-PCR product. Primers used for this amplification were F103 (5'-ACGCAGGAGATCGCC-GAC-3'), designed from the rat nucleotide sequence, and the R100 primer shown above. Northern blot hybridization was in 5 x SSPE, 10 x Denhardt's solution, 100 lJg/ ml salmon sperm DNA, 50% formamide, and 2% SDS at 42~ for 18 hr. Filters were washed with 2 x saline sodium citrate (SSC) at room temperature for 30 min and in 0.1• SSC at 60~ for 30 min. All blots were exposed to film overnight with a single intensifying screen at -70~
Mapping of the Mouse Cystatin B Gene
DNA for the BSS interspecific backcross panel was obtained from the Jackson Laboratory. The details of the BSS interspecific backcross are described in Rowe et al. (1994) . PCR was performed as described above with primers FIO0 and R100 on the two parental strains M. musculus and M. spretus. The 94-animal backcross panel was amplified and subjected to PstI restriction digestion. Digested PCR products were separated by 2% agarose gel electrophoresis. PstI digestion of the M. musculus PCR product resulted in two fragments -280 and 100 bp in length, whereas the PCR product of the M. spretus species was not cleaved by PstI, yielding a single fragment -400 bp in length.
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